Targeting EGFR in non-small-cell lung cancer

被引：23

作者：

Doroshow, JH ^{[1
]}

机构：

[1] NCI, Div Canc Treatment & Diag, Bethesda, MD 20892 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2005年 / 353卷 / 02期

关键词：

D O I：

10.1056/NEJMe058113

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：200 / 202

页数：3

共 12 条

[1] Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer
Cappuzzo, F
Hirsch, FR
Rossi, E
Bartolini, S
Ceresoli, GL
Bemis, L
Haney, J
Witta, S
Danenberg, K
Domenichini, I
Ludovini, V
Magrini, E
Gregorc, V
Doglioni, C
Sidoni, A
Tonato, M
Franklin, WA
Crino, L
Bunn, PA
Varella-Garcia, M
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (09): : 643 - 655
[2] ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines
Engelman, JA
Jänne, PA
Mermel, C
Pearlberg, J
Mukohara, T
Fleet, C
Cichowski, K
Johnson, BE
Cantley, LC
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (10) : 3788 - 3793
[3] Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: A phase III trial - INTACT 2
Herbst, RS
Giaccone, G
Schiller, JH
Natale, RB
Miller, V
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (05) : 785 - 794
[4] HERBST RS, 2004, P AN M AM SOC CLIN, V23, P617
[5] Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer - A randomized trial
Kris, MG
Natale, RB
Herbst, RS
Lynch, TJ
Prager, D
Belani, CP
Schiller, JH
Kelly, K
Spiridonidis, H
Sandler, A
Albain, KS
Cella, D
Wolf, MK
Averbuch, SD
Ochs, JJ
Kay, AC
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (16): : 2149 - 2158
[6] Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
Lynch, TJ
Bell, DW
Sordella, R
Gurubhagavatula, S
Okimoto, RA
Brannigan, BW
Harris, PL
Haserlat, SM
Supko, JG
Haluska, FG
Louis, DN
Christiani, DC
Settleman, J
Haber, DA
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) : 2129 - 2139
[7] EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
Paez, JG
Jänne, PA
Lee, JC
Tracy, S
Greulich, H
Gabriel, S
Herman, P
Kaye, FJ
Lindeman, N
Boggon, TJ
Naoki, K
Sasaki, H
Fujii, Y
Eck, MJ
Sellers, WR
Johnson, BE
Meyerson, M
[J]. SCIENCE, 2004, 304 (5676) : 1497 - 1500
[8] Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer: Current knowledge and future directions
Pao, W
Miller, VA
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (11) : 2556 - 2568
[9] Determinants of tumor response and survival with erlotinib in patients with non-small-cell lung cancer
Pérez-Soler, R
Chachoua, A
Hammond, LA
Rowinsky, EK
Huberman, M
Karp, D
Rigas, J
Clark, GM
Santabàrbara, P
Bonomi, P
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (16) : 3238 - 3247
[10] Erlotinib in previously treated non-small-cell lung cancer
Shepherd, FA
Pereira, JR
Ciuleanu, T
Tan, EH
Hirsh, V
Thongprasert, S
Campos, D
Maoleekoonpiroj, S
Smylie, M
Martins, R
van Kooten, M
Dediu, M
Findlay, B
Tu, DS
Johnston, D
Bezjak, A
Clark, G
Santabárbara, P
Seymour, L
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (02) : 123 - 132

← 1 2 →